Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 259

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Hypomagnesemia

AGUS, ZALMAN S.·1999·Journal of the American Society of Nephrology

Abstract

Hypomagnesemia is a common entity occurring in up to 12% of hospitalized patients (1). The incidence rises to as high as 60 to 65% in patients in intensive care settings in which nutrition, diuretics, hypoalbuminemia, and aminoglycosides may play important roles (2,3,4). Signs and Symptoms of Magnesium Depletion Symptomatic magnesium depletion is often associated with multiple biochemical abnormalities such as hypokalemia, hypocalcemia, and metabolic alkalosis. As a result, it is often difficult to ascribe specific clinical manifestations solely to hypomagnesemia. In 1960, five patients were reported with symptoms considered to be typical of magnesium depletion, including tetany, positive Chvostek and Trousseau signs, and generalized convulsions (5). Somewhat similar findings—generalized weakness, anorexia, hypokalemia, hypocalcemia, and positive Trousseau and Chvostek signs—were noted when magnesium depletion was induced in volunteers (6). Tetany can occur in the absence of hypocalcemia and alkalosis and is presumably due to lowering of the threshold for nerve stimulation (7). Hypokalemia Hypokalemia is a common event in hypomagnesemic patients, occurring in 40 to 60% of cases (8). This relationship is in part due to underlying disorders that cause both magnesium and potassium loss, such as diuretic therapy and diarrhea. There is also evidence of renal potassium wasting in hypomagnesemic patients (6) that is likely due to increased potassium secretion in the loop of Henle and perhaps the cortical collecting tubule. There are several mechanisms that may explain how this might occur. Potassium secretion from the cell into the lumen in the cells of the thick ascending limb and cortical collecting tubule is mediated by ATP-inhibitable luminal potassium channels (9). Hypomagnesemia is associated with a reduction in cell magnesium concentration, which may then lead to a decline in ATP activity, and, due to removal of ATP inhibition, an increase in the number of open potassium channels (9). In addition, decreasing cytosolic magnesium has been shown to directly increase the activity of potassium channels of ascending limb cells (10). Given the very high cell potassium concentration, these changes would promote potassium secretion from the cell into the lumen and enhanced urinary losses. The hypokalemia in this setting is relatively refractory to potassium supplementation and requires correction of the magnesium deficit (11). Bone and Calcium Metabolism The most classical sign of severe hypomagnesemia (<1.0 mEq/L, 0.5 mmol/L, or 1.2 mg/dl) is hypocalcemia. Early in vitro studies showed that a reduction in extracellular magnesium concentration stimulated the secretion of parathyroid hormone (PTH) in the absence of changes in calcium concentration. However, immunoreactive PTH levels in most hypomagnesemic-hypocalcemic patients have been either normal or low (and in some cases undetectable), indicating inappropriately low PTH secretion (12,13). Further evidence for a suppressive effect of hypomagnesemia on PTH secretion is the observation that, in the majority of these patients, parenteral magnesium supplementation leads to a rapid rise in plasma PTH levels (12,13). Several other factors play a role in the mechanism of the hypocalcemia. Parathyroid Hormone Resistance. Failure of hormone secretion cannot explain all of the hypocalcemia, as bone resistance to PTH also plays a role (13). Studies in isolated perfused bone have shown that magnesium depletion interferes with the generation of cAMP in response to perfusion with PTH (14). Why this occurs is not clear. It is possible that severe hypomagnesemia may interfere with G protein activation in response to PTH, thereby minimizing the stimulation of adenylate cyclase. Several findings suggest that PTH resistance may be of greater importance than diminished secretion in most patients. In general, PTH-induced release of calcium from bone is substantially impaired when the plasma magnesium concentration falls below 0.8 mEq/L (1 mg/dl or 0.4 mmol/L); in comparison, diminished PTH secretion appears to require more severe hypomagnesemia. Furthermore, there may be a variable time course for the normalization of the different aspects of calcium and PTH metabolism in hypomagnesemic patients. In some patients, PTH secretion rises significantly earlier than correction of hypocalcemia and restoration of PTH responsiveness (13). This observation is compatible with a primary role for PTH resistance. As noted above, symptomatic hypocalcemia is almost always associated with plasma magnesium levels below 1.0 mEq/L (0.5 mmol/L or 1.2 mg/dl). Mild hypomagnesemia (plasma magnesium concentration between 1.1 and 1.3 mEq/L) can also lower the plasma calcium concentration, but the change is quite small (0.2 mg/dl or 0.05 mmol/L) (15). Vitamin D Deficiency. Low plasma levels of calcitriol (1,25-dihydroxyvitamin D, the most active metabolite of vitamin D) have been noted in hypocalcemic, hypomag

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.v1071616

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 259

Metadata

Authors
AGUS, Z. S.
Venue
Journal of the American Society of Nephrology
Published
1999-07
Volume
10
Issue
7
Pages
1616-1622
ISSN
1046-6673 (ISSN-L)
OpenAlex
W4253241607
Cited by
259
References
23
FWCI
2.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypomagnesemia. https://app.cochat.ai/papers/10.1681/asn.v1071616
The paper
AGUS, Z. S. (1999). Hypomagnesemia. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v1071616

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.